Who owns AKOYA BIOSCIENCES INC?
- Ticker: AKYA
- CUSIP Number: 00974h104
Tip: Access positions for across all investors
Analyze quarterly positions in Akoya Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Akoya Biosciences stock
Who bought or sold AKOYA BIOSCIENCES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Blue Water Life Science Advisors | 4.7M | $22M | 0% | Mar 2024 |
|
| Vanguard Group | 1.5M | $6.8M | 3% | Mar 2024 |
|
| BlackRock | 1.3M | $6.3M | -7% | Mar 2024 |
|
| Parkman Healthcare Partners | 917k | $4.3M | 75% | Mar 2024 |
|
| Uniplan Investment Counsel | 700k | $3.3M | 26% | Mar 2024 |
|
| Silvercrest Asset Management Group | 581k | $2.7M | 100% | Mar 2024 |
|
| Bp Wealth Management | 515k | $2.4M | 0% | Mar 2024 |
|
| Geode Capital Management | 514k | $2.4M | 10% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 376k | $1.8M | 141% | Mar 2024 |
|
| Peddock Capital Advisors | 240k | $1.1M | -17% | Mar 2024 |
|
| Northern Trust | 207k | $973k | 13% | Mar 2024 |
|
| Charles Schwab Investment Management | 172k | $806k | -16% | Mar 2024 |
|
| Squarepoint Ops | 138k | $649k | 43% | Mar 2024 |
|
| Osterweis Capital Management | 126k | $592k | 0% | Mar 2024 |
|
| Citadel Advisors | 69k | $322k | 197% | Mar 2024 |
|
| Susquehanna International | 64k | $300k | 187% | Mar 2024 |
|
| Morgan Stanley | 64k | $299k | 90% | Mar 2024 |
|
| Bank of New York Mellon | 58k | $272k | -32% | Mar 2024 |
|
| Millennium Management | 50k | $237k | -68% | Mar 2024 |
|
| ZWJ Investment Counsel | 45k | $212k | 0% | Mar 2024 |
|
| Nuveen Asset Management | 41k | $192k | 39% | Mar 2024 |
|
| Ameriprise Financial | 35k | $163k | -23% | Mar 2024 |
|
| Rhumbline Advisers | 34k | $159k | 2% | Mar 2024 |
|
| Cubist Systematic Strategies | 29k | $136k | -12% | Mar 2024 |
|
| HighTower Advisors | 27k | $128k | 0% | Mar 2024 |
|
| Alliancebernstein | 27k | $133k | 0% | Dec 2023 |
|
| XTX Topco | 25k | $118k | 100% | Mar 2024 |
|
| Marshall Wace | 22k | $103k | 100% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 22k | $102k | 0% | Mar 2024 |
|
| UBS Group | 21k | $101k | -16% | Mar 2024 |
|
| Bridgeway Capital Management | 21k | $96k | 100% | Mar 2024 |
|
| Dimensional Fund Advisors | 18k | $86k | 0% | Mar 2024 |
|
| Barclays | 18k | $84k | -46% | Mar 2024 |
|
| Sherbrooke Park Advisers | 16k | $75k | 100% | Mar 2024 |
|
| GSA Capital Partners | 16k | $74k | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 15k | $69k | 0% | Mar 2024 |
|
| Jane Street | 13k | $63k | -39% | Mar 2024 |
|
| Stephens | 13k | $59k | -89% | Mar 2024 |
|
| Goldman Sachs Group | 12k | $58k | 22% | Mar 2024 |
|
| New York State Common Retirement Fund | 12k | $55k | 0% | Mar 2024 |
|
| American International | 12k | $56k | 3% | Dec 2023 |
|
| Regal Investment Advisors | 11k | $54k | 100% | Mar 2024 |
|
| Stifel Financial | 11k | $50k | 0% | Mar 2024 |
|
| Bank of America Corporation | 9.7k | $46k | -56% | Mar 2024 |
|
| Wells Fargo & Company | 6.9k | $33k | 15% | Mar 2024 |
|
| NISA Investment Advisors | 6.1k | $28k | 0% | Mar 2024 |
|
| HighMark Wealth Management | 4.0k | $19k | 100% | Mar 2024 |
|
| Citigroup | 3.9k | $18k | 13% | Mar 2024 |
|
| Group One Trading | 3.0k | $14k | 100% | Mar 2024 |
|
| FMR | 2.5k | $12k | -32% | Mar 2024 |
|
| Legal & General Group | 2.5k | $12k | -8% | Mar 2024 |
|
| Qube Research & Technologies | 2.4k | $11k | -93% | Mar 2024 |
|
| California State Teachers Retirement System | 2.3k | $11k | -53% | Mar 2024 |
|
| Sit Investment Associates | 1.9k | $9.0k | 0% | Mar 2024 |
|
| Tower Research Capital | 1.3k | $6.2k | -51% | Mar 2024 |
|
| Summit Investment Advisors | 1.2k | $5.6k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 1.0k | $4.9k | -87% | Mar 2024 |
|
| Amalgamated Bank | 465.00 | $2.0k | -81% | Mar 2024 |
|
| Point72 | 429.00 | $2.0k | 100% | Mar 2024 |
|
| Steward Partners Investment Advisory | 400.00 | $1.9k | 0% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 326.00 | $1.5k | 100% | Mar 2024 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 200.00 | $0 | 0% | Mar 2024 |
|
| Capital Advisors | 59.00 | $0 | 0% | Mar 2024 |
|
| Russell Investments | 34.00 | $159.001000 | 100% | Mar 2024 |
|
| Farther Finance Advisors | 4.00 | $18.000000 | 0% | Mar 2024 |
|
Who sold out of Akoya Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Board of Trustees of The Leland Stanford Junior University | Dec 2023 | 620k | $3.0M |
| Kent Lake Capital | Dec 2023 | 117k | $570k |
| Weiss Multi-strategy Advisers | Dec 2023 | 51k | $249k |
| Trexquant Investment | Sep 2023 | 50k | $234k |
| CIBC Global Asset Management | Sep 2023 | 42k | $195k |
| Engineers Gate Manager | Sep 2023 | 15k | $69k |
| State of Wisconsin Investment Board | Dec 2023 | 15k | $71k |
| Point72 Middle East FZE | Dec 2023 | 6.4k | $31k |
| Glassman Wealth Services | Dec 2023 | 50.00 | $244.000000 |
| Pnc Financial Services | Dec 2023 | 17.00 | $83.000800 |